The World Health Organization's has declared global emergency on the spread of Mpox
South Korean company Seegene providing a total solution for PCR molecular diagnostics, has developed its PCR test assays in response to the public health emergency of international concern (PHEIC) declared by the World Health Organization's (WHO) on the global spread of mpox.
The products, which are intended for research use only (RUO), include Novaplex MPXV/OPXV Assay (RUO) and Novaplex HSV-1&2/VZV/MPXV Assay (RUO). In particular, Novaplex HSV-1&2/VZV/MPXV Assay (RUO) is designed to detect four viruses including Mpox virus and other key STI-causing pathogens.
Seegene previously developed Novaplex MPXV (RUO) in 2022 using its advanced Seegene Digitalized Development System (SGDDS), which was developed based on Seegene's expertise to rapidly create and deploy new assays.
"We will closely collaborate with governments around the world that need assays and plan to supply them with products meeting the needs of their respective markets," said Daniel Shin, Executive Vice-President and Chief Global Sales and Marketing Officer, Seegene.